Skip to main content
SpringerLink
Log in

Experimental Strategies for Combined Suicide and Immune Cancer Gene Therapy

An Overview

  • Protocol
Cytokines and Colony Stimulating Factors

Part of the book series: Methods in Molecular Biology ((MIMB,volume 215))

  • 523 Accesses

Abstract

Suicide gene therapy systems are characterized by the transfer of therapeutic transgenes, which encode for enzymes of various origins. These enzymes are able to convert nontoxic prodrugs into highly cytotoxic metabolites. Thus, all cells that are transduced by suicide genes will be destroyed when the corresponding prodrug is applied. The cytotoxicity is mostly limited to transduced cells, but nontransduced cells may also be affected by the so-called bystander effect. The bystander effect (1) describes the phenomenon that in cell culture only a relatively small amount of cells has to be transduced with the suicide gene to gain complete cell killing upon treatment with the corresponding prodrug.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Moolten, F. L. and Wells, J. M. (1990) Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J. Natl. Cancer Inst. 82, 297–300.

    CAS  Google Scholar 

  2. Aghi, M., Hochberg, F., and Breakefield, X. O. (2000) Prodrug activating enzymes in cancer gene therapy. J. Gene Med. 2, 148–164.

    CAS  Google Scholar 

  3. Elion, G. B. (1983) The biochemistry and mechanism of action of acyclovir. J. Antimicrob. Chemother. 12 (Suppl. B), 9–17.

    CAS  Google Scholar 

  4. Polak, A. (1990) Mode of action studies. B. Target nucleic acid synthesis and cell division. I. 5-Fluorocytosine, in Chemotherapy of Fungal Diseases, ed.), Springer-Verlag, Berlin, pp. 155–159.

    Google Scholar 

  5. Gagandeep, S., Brew, R., Green, B., Christmas, S. E., Klatzmann, D., Poston, G. J., et al. (1996) Prodrug-activated gene therapy: involvement of an immunological component in the &quote;bystander effect.&quote; Cancer Gene Ther. 3, 83–88.

    CAS  Google Scholar 

  6. Barba, D., Hardin, J., Sadelain, M., and Gage, F. H. (1994) Development of antitumor immunity following thymidine kinase mediated killing of experimental brain tumors. PNAS 91, 4348–4352.

    CAS  Google Scholar 

  7. Mullen, C. A., Coale, M. M., Lowe, R., and Blaese, R. M. (1994) Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor. Cancer Res. 54, 1503–1506.

    CAS  Google Scholar 

  8. Caruso, M., Panis, Y., Gagandeep, S., Houssin, D., Salzmann, J. L., and Klatzmann, D. (1993) Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. PNAS 90, 7024–7028.

    CAS  Google Scholar 

  9. Consalvo, M., Mullen, C. A., Modesti, A., Musiani, P., Allione, A., Cavallo, F., et al. (1995) 5-Fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory. J. Immunol. 154, 5302–5312.

    CAS  Google Scholar 

  10. Hall, S. J., Sanford, M. A., Atkinson, G., and Chen, S. H. (1998) Induction of a potent antitumor natural killer cell activity by herpes simplex virus-thymidine kinase and ganciclovir therapy in an orthotopic mouse model of prostate cancer. Cancer Res. 58, 3221–3225.

    CAS  Google Scholar 

  11. Freeman, S. M., Ramesh, R., and Marrogi, A. J. (1997) Immune system in suicidegene therapy. Lancet 349, 2–3.

    CAS  Google Scholar 

  12. Ramesh, R., Marrogi, A. J., Munshi, A., Abboud, C. A., and Freeman, S. M. (1996) In vivo analysis of the &quote;bystander effect&quote;: a cytokine cascade. Exp. Hematol. 24, 829–838.

    CAS  Google Scholar 

  13. Vile, R. G., Castleden, S., Marshall, J., Camplejohn, R., Upto, C., and Chong, H. (1997) Generation of an anti-tumour immune response in a non-immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a TH1-like profile of intratumoural cytokine expression. Int. J. Cancer 71, 267–274.

    CAS  Google Scholar 

  14. Felzmann, T., Ramsey, W. J., and Blaese, R. M. (1997) Characterization of the antitumor immune response generated by treatment of murine tumors with recombinant adenoviruses expressing HSVtk, IL-2, IL-6 or B7-1. Gene Ther. 4, 1322–1329.

    CAS  Google Scholar 

  15. Mullen, C. A., Anderson, L., Woods, K., Nishino, M., and Petropoulos, D. (1998) Ganciclovir chemoablation of herpes thymidine kinase suicide gene-modified tumors produces tumor necrosis and induces systemic immune responses. Hum. Gene Ther. 9, 2019–2030.

    CAS  Google Scholar 

  16. Ram, Z., Walbridge, S., Heiss, J. D., Culver, K. W., Blaese, R. M., and Oldfield, E. H. (1994) In vivo transfer of the human interleukin-2: negative tumoricidal results in experimental brain tumors. J. Neurosurg. 80, 535–540.

    CAS  Google Scholar 

  17. Chen, S. H., Chen, X. H., Wang, Y., Kosai, K., Finegold, M. J., Rich, S. S., et al. (1995) Combination gene therapy for liver metastasis of colon carcinoma in vivo. PNAS 92, 2577–2581.

    CAS  Google Scholar 

  18. Coll, J. L., Mesnil, M., Lefebvre, M. F., Lancon, A., and Favrot, M. C. (1997) Long-term survival of immunocompetent rats with intraperitoneal colon carcinoma tumors using herpes simplex thymidine kinase/ganciclovir and IL-2 treatments. GeneTher. 4, 1160–1166.

    CAS  Google Scholar 

  19. O’Malley, B. W., Cope, K. A., Chen, S. H., Li, D., Schwarta, M. R., and Woo, S. L. (1996) Combination gene therapy for oral cancer in a murine model. Cancer Res. 56, 1737–1741.

    CAS  Google Scholar 

  20. O’Malley, B. W., Jr., Sewell, D. A., Li, D., Kosai, K., Chen, S. H., Woo, S. L., et al. (1997) The role of interleukin-2 in combination adenovirus gene therapy for head and neck cancer. Mol. Endocrinol. 11, 667–673.

    CAS  Google Scholar 

  21. Kwong, Y. L., Chen, S. H., Kosai, K., Finegold, M., and Woo, S. L. (1997) Combination therapy with suicide and cytokine genes for hepatic metastases of lung cancer. Chest 112, 1332–1337.

    CAS  Google Scholar 

  22. O’Malley, B. W., Jr. and Li, D. (1998) Combination gene therapy for salivary gland cancer. Ann. NYAcad. Sci. 842, 163–170.

    CAS  Google Scholar 

  23. Chen, S. H., Kosai, K. K., Xu, B., Pham-Nguyen, K., Constant, C., Finegold, M. J., et al. (1996) Combination suicide and cytokine gene therapy for hepatic metastases of colon carcinoma: sustained antitumor immunity prolongs animal survival. Cancer Res. 56, 3758–3762.

    CAS  Google Scholar 

  24. Benedetti, S., Dimeco, F., Pollo, B., Cirenei, N., Colombo, B. M., Bruzzone, M. G., et al. (1997) Limited efficacy of the HSV-Tk/GCV system for gene therapy of malignant gliomas and perspectives for the combined transduction of the interleukin-4 gene. Hum. Gene Ther. 8, 1345–1353.

    CAS  Google Scholar 

  25. Sharma, S., Miller, P. W., Stolina, M., Zhu, L., Huang, M., Paul, R. W., et al. (1997) Multicomponent gene therapy vaccines for lung cancer: effective eradication of established murine tumors in vivo with interleukin-7/herpes simplex thymidine kinase-transduced autologous tumor and ex vivo activated dentritic cells. Gene Ther. 4, 1361–1370.

    CAS  Google Scholar 

  26. Hayashi, S., Emi, N., Yokoyama, I., Namii, Y., Uchida, K., and Takagi, H. (1997) Inhibition of establishment of hepatic metastasis in mice by combination gene therapy using both herpes simplex virus-thymidine kinase and granulocyte macrophage-colony stimulating factor genes in murine colon cancer. Cancer Gene Ther. 4, 339–344.

    CAS  Google Scholar 

  27. Santodonato, L., D’Agostino, G., Santini, S. M., Carlei, D., Musiani, P., Modesti, A., et al. (1997) Local and systemic antitumor response after combined therapy of mouse metastatic tumor cells expressing IFN-alpha and HSVtk: perspectives for the generation of cancer vaccines. Gene Ther. 4, 1246–1255.

    CAS  Google Scholar 

  28. Ju, D. W., Wang, B. M., and Cao, X. (1998) Adenovirus-mediated combined suicide gene and interleukin-2 gene therapy for the treatment of established tumor and induction of antitumor immunity. J. Cancer Res. Clin. Oncol. 124, 683–689.

    CAS  Google Scholar 

  29. Ju, D., Cao, X., and Wang, B. (1998) Therapeutic effects of combined suicide gene and cytokine gene therapy on erythroleukemia-bearing mice. Zhonghua Xue Ye Xue Za Zhi 19, 294–298.

    CAS  Google Scholar 

  30. Ju, D., Cao, X., and Wang, B. (1998) Antitumor effect of combined therapy with adenovirus-mediated CD suicide gene and interleukin 2 gene transfer and its immunological mechanism. Zhonghua Zhong Liu Za Zhi 20, 108–111.

    CAS  Google Scholar 

  31. Missol-Kolka, E., Sochanik, A., and Szala, S. (1998) Combined therapy of B16(F10) murine melanoma using E. coli cytosine deaminase gene and murine interleukin-4 gene. Neoplasma 45, 305–311.

    CAS  Google Scholar 

  32. Bonnekoh, B., Greenhalgh, D. A., Chen, S. H., Block, A., Rich, S. S., Krieg, T., et al. (1998) Ex vivo and in vivo adenovirus-mediated gene therapy strategies induce a systemic anti-tumor immune defence in the B16 melanoma model. J. Invest. Dermatol. 110, 867–871.

    CAS  Google Scholar 

  33. Cao, X., Ju, D. W., Tao, Q., Wang, J., Wan, T., Wang, B. M., et al. (1998) Adenovirus-mediated GM-CSF gene and cytosine deaminase gene transfer followed by 5-fluorocytosine administration elicit more potent antitumor response in tumor-bearing mice. Gene Ther. 5, 1130–1136.

    CAS  Google Scholar 

  34. Nanni, P., De Giovanni, C., Nicoletti, G., Landuzzi, L., Rossi, I., Frabetti, F., et al. (1998) The immune response elicited by mammary adenocarcinoma cells transduced with interferon-gamma and cytosine deaminase genes cures lung metastases by parental cells. Hum. Gene Ther. 9, 217–224.

    CAS  Google Scholar 

  35. Moriuchi, S., Oligino, T., Krisky, D., Marconi, P., Fink, D., Cohen, J., et al. (1998) Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpression of human tumor necrosis factor-alpha and herpes simplex virus thymidine kinase. Cancer Res. 58, 5731–5737.

    CAS  Google Scholar 

  36. Soler, M. N., Milhaud, G., Lekmine, F., Treilhou-Lahille, F., Klatzmann, D., and Lausson, S. (1999) Treatment of medullary thyroid carcinoma by combined expression of suicide and interleukin-2 genes. Cancer Immunol. Immunother. 48, 91–99.

    CAS  Google Scholar 

  37. Ju, D. W., Tao, Q., Cheng, D. S., Zhang, W., Zhang, M., Hamada, H., et al. (2000) Adenovirus-mediated lymphotactin gene transfer improves therapeutic efficacy of cytosine deaminase suicide gene therapy in established murine colon carcinoma Gene Ther. 7, 329–338.

    CAS  Google Scholar 

  38. Drozdzik, M., Qian, C., Xie, X., Peng, D., Bilbao, R., Mazzolini, G., et al. (2000) Combined gene therapy with suicide gene and interleukin-12 is more efficient than therapy with one gene alone in a murine model of hepatocellular carcinoma. J. Hepatol. 32, 279–286.

    CAS  Google Scholar 

  39. Cao, X., Huang, X., Ju, D. W., Zhang, W., Hamada, H., and Wang, J. (2000) Enhanced antitumoral effect of adenovirus-mediated cytosine deaminase gene therapy by induction of antigen-presenting cells through stem cell factor/granulocytemacrophage colony-stimulating factor gene transfer. Cancer Gene Ther. 7, 177–186.

    CAS  Google Scholar 

  40. Majumdar, A. S., Zolotorev, A., Samuel, S., Tran, K., Vertin, B., Hall-Meier, M., et al. (2000) Efficacy of herpes simplex virus thymidine kinase in combination with cytokine gene therapy in an experimental metastatic breast cancer model. Cancer Gene Ther. 7, 1086–1099.

    CAS  Google Scholar 

  41. Freund, C. T., Sutton, M. A., Dang, T., Contant, C. F., Rowley, D., and Lerner, S. P. (2000) Adenovirus-mediated combination suicide and cytokine gene therapy for bladder cancer. Anticancer Res. 20, 1359–1365.

    CAS  Google Scholar 

  42. Lechanteur, C., Delvenne, P., Princen, F., Lopez, M., Fillet, G., Gielen, J., et al. (2000) Combined suicide and cytokine gene therapy for peritoneal carcinomatosis. Gut 47, 343–348.

    CAS  Google Scholar 

  43. Niranjan, A., Moriuchi, S., Lunsford, L. D., Kondziolka, D., Flickinger, J. C., Fellows, W., et al. (2000) Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration. Mol. Ther. 2, 114–120.

    CAS  Google Scholar 

  44. Jones, R. K., Pope, I. M., Kinsella, A. R., Watson, A. J., and Christmas, S. E. (2000) Combined suicide and granulocyte-macrophage colony-stimulating factor gene therapy induces complete tumor regression and generates antitumor immunity. Cancer Gene Ther. 7(12), 1519–1528.

    CAS  Google Scholar 

  45. Ju, D. W., Yang, Y., Tao, Q., Song, W. G., He, L., Chen, G., et al. (2000) Interleukin-18 gene transfer increases antitumor effects of suicide gene therapy through efficient induction of antitumor immunity. Gene Ther. 7, 1672–1679.

    CAS  Google Scholar 

  46. Toda, M., Martuza, R. L., and Rabkin, S. D. (2001) Combination suicide/cytokine gene therapy as adjuvants to a defective herpes simplex virus-based cancer vaccine. Gene Ther. 8, 332–339.

    CAS  Google Scholar 

  47. Ram, Z., Culver, K. W., Oshiro, E. M., Viola, J. J., DeVroom, H. L., Otto, E., et al. (1997) Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat. Med. 3, 1354–1361.

    CAS  Google Scholar 

  48. Rainov, N. G. (2000) A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum. Gene Ther. 11, 2389–2401.

    CAS  Google Scholar 

  49. Kramm, C. M., Sena-Esteves, M., Barnett, F. H., Rainov, N. G., Schuback, D. E., Yu, J. S., et al. (1995) Gene therapy for brain tumors. Brain Pathol. 5, 345–381.

    CAS  Google Scholar 

  50. Agrawal, R. S., Karhu, K., Laukkanen, J., Kirkinen, P., Yla-Herttuala, S., and Agrawal, Y. P. (1999) Complement and anti-alpha-galactosyl natural antibodymediated inactivation of murine retrovirus occurs in adult serum but not in umbilical cord serum. Gene Ther. 6, 146–148.

    CAS  Google Scholar 

  51. Short, M. P., Choi, B. C., Lee, J. K., Malick, A., Breakefield, X. O., and Martuza, R. L. (1990) Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line. J. Neurosci. Res. 27, 427–439.

    CAS  Google Scholar 

  52. Bonini, C., Ferrari, G., Verzeletti, S., Servida, P., Zappone, E., Ruggieri, L., et al. (1997) HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 276, 1719–1724.

    CAS  Google Scholar 

  53. Cavazzana-Calvo, M., Hacein-Bey, S., de Saint Basile, G., Gross, F., Yvon, E., Nusbaum, P., et al. (2000) Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288, 669–672.

    CAS  Google Scholar 

  54. Marshall, E. (1999) Gene therapy death prompts review of adenovirus vector. Science 286, 2244–2245.

    CAS  Google Scholar 

  55. Kochanek, S. (1999) High-capacity adenoviral vectors for gene transfer and somatic gene therapy. Hum. Gene Ther. 10, 2451–2459.

    CAS  Google Scholar 

  56. Boviatsis, E. J., Chase, M., Wei, M. X., Tamiya, T., Hurford, R. K., Jr., Kowall, N. W., et al. (1994) Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors. Hum. Gene Ther. 5, 183–191.

    CAS  Google Scholar 

  57. Kramm, C. M., Rainov, N. G., Sena-Esteves, M., Barnett, F. H., Chase, M., Herrlinger, U., et al. (1996) Long-term survival in a rodent model of disseminated brain tumors by combined intrathecal delivery of herpes vectors and ganciclovir treatment. Hum. Gene Ther. 7, 1989–1994.

    CAS  Google Scholar 

  58. Markert, J. M., Medlock, M. D., Rabkin, S. D., Gillespie, G. Y., Todo, T., Hunter, W. D., et al. (2000) Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial. Gene Ther. 7, 867–874.

    CAS  Google Scholar 

  59. Palu, G., Cavaggioni, A., Calvi, P., Franchin, E., Pizzato, M., Boschetto, R., et al. (1999) Gene therapy of glioblastoma multiforme via combined expression of suicide and cytokine genes: a pilot study in humans. Gene Ther. 6, 330–337.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatric Hematology and Oncology, University Hospital, Heinrich-Heine-University, Düsseldorf, Germany

    Christof M. Kramm

  2. Hematology and Oncology, University Hospital, Heinrich-Heine-University, Düsseldorf, Germany

    Tim Niehues

  3. Walton Centre for Neurology and Neurosurgery, University of Liverpool, UK

    Nikolai G. Rainov

Authors
  1. Christof M. Kramm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tim Niehues
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nikolai G. Rainov
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pediatrics, University of Leipzig, Leipzig, Germany

    Dieter Körholz  & Wieland Kiess  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Humana Press Inc.

About this protocol

Cite this protocol

Kramm, C.M., Niehues, T., G. Rainov, N. (2003). Experimental Strategies for Combined Suicide and Immune Cancer Gene Therapy. In: Körholz, D., Kiess, W. (eds) Cytokines and Colony Stimulating Factors. Methods in Molecular Biology, vol 215. Humana, Totowa, NJ. https://doi.org/10.1385/1-59259-345-3:137

Download citation

  • DOI: https://doi.org/10.1385/1-59259-345-3:137

  • Publisher Name: Humana, Totowa, NJ

  • Print ISBN: 978-1-58829-035-9

  • Online ISBN: 978-1-59259-345-3

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation